605 related articles for article (PubMed ID: 26832737)
21. Retention and mortality on antiretroviral therapy in sub-Saharan Africa: collaborative analyses of HIV treatment programmes.
Haas AD; Zaniewski E; Anderegg N; Ford N; Fox MP; Vinikoor M; Dabis F; Nash D; Sinayobye JD; Niyongabo T; Tanon A; Poda A; Adedimeji AA; Edmonds A; Davies MA; Egger M;
J Int AIDS Soc; 2018 Feb; 21(2):. PubMed ID: 29479867
[TBL] [Abstract][Full Text] [Related]
22. Estimation of mortality among HIV-infected people on antiretroviral treatment in East Africa: a sampling based approach in an observational, multisite, cohort study.
Geng EH; Odeny TA; Lyamuya RE; Nakiwogga-Muwanga A; Diero L; Bwana M; Muyindike W; Braitstein P; Somi GR; Kambugu A; Bukusi EA; Wenger M; Wools-Kaloustian KK; Glidden DV; Yiannoutsos CT; Martin JN
Lancet HIV; 2015 Mar; 2(3):e107-16. PubMed ID: 26424542
[TBL] [Abstract][Full Text] [Related]
23. Outcomes of a nurse-managed service for stable HIV-positive patients in a large South African public sector antiretroviral therapy programme.
Grimsrud A; Kaplan R; Bekker LG; Myer L
Trop Med Int Health; 2014 Sep; 19(9):1029-39. PubMed ID: 25041716
[TBL] [Abstract][Full Text] [Related]
24. Trends in CD4 count at presentation to care and treatment initiation in sub-Saharan Africa, 2002-2013: a meta-analysis.
Siedner MJ; Ng CK; Bassett IV; Katz IT; Bangsberg DR; Tsai AC
Clin Infect Dis; 2015 Apr; 60(7):1120-7. PubMed ID: 25516189
[TBL] [Abstract][Full Text] [Related]
25. Outcomes of Nigeria's HIV/AIDS Treatment Program for Patients Initiated on Antiretroviral Treatment between 2004-2012.
Dalhatu I; Onotu D; Odafe S; Abiri O; Debem H; Agolory S; Shiraishi RW; Auld AF; Swaminathan M; Dokubo K; Ngige E; Asadu C; Abatta E; Ellerbrock TV
PLoS One; 2016; 11(11):e0165528. PubMed ID: 27829033
[TBL] [Abstract][Full Text] [Related]
26. Monitoring and switching of first-line antiretroviral therapy in adult treatment cohorts in sub-Saharan Africa: collaborative analysis.
Haas AD; Keiser O; Balestre E; Brown S; Bissagnene E; Chimbetete C; Dabis F; Davies MA; Hoffmann CJ; Oyaro P; Parkes-Ratanshi R; Reynolds SJ; Sikazwe I; Wools-Kaloustian K; Zannou DM; Wandeler G; Egger M;
Lancet HIV; 2015 Jul; 2(7):e271-8. PubMed ID: 26423252
[TBL] [Abstract][Full Text] [Related]
27. Similar mortality and reduced loss to follow-up in integrated compared with vertical programs providing antiretroviral treatment in sub-saharan Africa.
Greig J; O'Brien DP; Ford N; Spelman T; Sabapathy K; Shanks L
J Acquir Immune Defic Syndr; 2012 Apr; 59(5):e92-8. PubMed ID: 22134144
[TBL] [Abstract][Full Text] [Related]
28. Incidence and predictors of early loss to follow up among patients initiated on protease inhibitor-based second-line antiretroviral therapy in southwestern Uganda.
Nuwagira E; Lumori BAE; Muhindo R; Kanyesigye M; Amir A; Muyindike W; Muzoora C
AIDS Res Ther; 2021 Mar; 18(1):7. PubMed ID: 33743748
[TBL] [Abstract][Full Text] [Related]
29. Determinants of time to antiretroviral treatment initiation and subsequent mortality on treatment in a cohort in rural northern Malawi.
Brown JP; Ngwira B; Tafatatha T; Crampin AC; French N; Koole O
AIDS Res Ther; 2016; 13():24. PubMed ID: 27398087
[TBL] [Abstract][Full Text] [Related]
30. Outcomes in a Cohort of Patients Started on Antiretroviral Treatment and Followed up for a Decade in an Urban Clinic in Uganda.
Castelnuovo B; Kiragga A; Musaazi J; Sempa J; Mubiru F; Wanyama J; Wandera B; Kamya MR; Kambugu A
PLoS One; 2015; 10(12):e0142722. PubMed ID: 26642214
[TBL] [Abstract][Full Text] [Related]
31. Trends in and correlates of CD4+ cell count at antiretroviral therapy initiation after changes in national ART guidelines in Rwanda.
Mutimura E; Addison D; Anastos K; Hoover D; Dusingize JC; Karenzie B; Izimukwiye I; Mutesa L; Nsanzimana S; Nash D;
AIDS; 2015 Jan; 29(1):67-76. PubMed ID: 25562492
[TBL] [Abstract][Full Text] [Related]
32. Variations in the characteristics and outcomes of children living with HIV following universal ART in sub-Saharan Africa (2006-17): a retrospective cohort study.
Iyun V; Technau KG; Vinikoor M; Yotebieng M; Vreeman R; Abuogi L; Desmonde S; Edmonds A; Amorissani-Folquet M; Davies MA;
Lancet HIV; 2021 Jun; 8(6):e353-e362. PubMed ID: 33932330
[TBL] [Abstract][Full Text] [Related]
33. Dropout from care among HIV-infected patients enrolled in care at a tertiary HIV care center in Chennai, India.
Blutinger EJ; Solomon S; Srikrishnan AK; Thamburaj E; Kumarasamy N; Balakrishnan P; Anand S; Ganesh AK; Solomon SS
AIDS Care; 2014; 26(12):1500-5. PubMed ID: 25011519
[TBL] [Abstract][Full Text] [Related]
34. Treatment outcomes and their determinants in HIV patients on Anti-retroviral Treatment Program in selected health facilities of Kembata and Hadiya zones, Southern Nations, Nationalities and Peoples Region, Ethiopia.
Ayele W; Mulugeta A; Desta A; Rabito FA
BMC Public Health; 2015 Aug; 15():826. PubMed ID: 26310943
[TBL] [Abstract][Full Text] [Related]
35. Prognostic value of virological and immunological responses after 6 months of antiretroviral treatment in adults with HIV-1 infection in sub-Saharan Africa.
De Luca A; Marazzi MC; Mancinelli S; Ceffa S; Altan AM; Buonomo E; Prosperi MC; Pedruzzi B; Noorjehan AM; Scarcella P; Liotta G; Palombi L
J Acquir Immune Defic Syndr; 2012 Mar; 59(3):236-44. PubMed ID: 22327246
[TBL] [Abstract][Full Text] [Related]
36. Twelve-year mortality in adults initiating antiretroviral therapy in South Africa.
Cornell M; Johnson LF; Wood R; Tanser F; Fox MP; Prozesky H; Schomaker M; Egger M; Davies MA; Boulle A;
J Int AIDS Soc; 2017 Sep; 20(1):21902. PubMed ID: 28953328
[TBL] [Abstract][Full Text] [Related]
37. Prognosis of patients with HIV-1 infection starting antiretroviral therapy in sub-Saharan Africa: a collaborative analysis of scale-up programmes.
May M; Boulle A; Phiri S; Messou E; Myer L; Wood R; Keiser O; Sterne JA; Dabis F; Egger M;
Lancet; 2010 Aug; 376(9739):449-57. PubMed ID: 20638120
[TBL] [Abstract][Full Text] [Related]
38. Factors Associated with Timing of Initiation of Antiretroviral Therapy among HIV-1 Infected Adults in the Niger Delta Region of Nigeria.
Ogoina D; Finomo F; Harry T; Inatimi O; Ebuenyi I; Tariladei WW; Afolayan AA
PLoS One; 2015; 10(5):e0125665. PubMed ID: 25933356
[TBL] [Abstract][Full Text] [Related]
39. Predictors of early mortality in a cohort of HIV-infected children receiving high active antiretroviral treatment in public hospitals in Ethiopia.
Ebissa G; Deyessa N; Biadgilign S
AIDS Care; 2015; 27(6):723-30. PubMed ID: 25599414
[TBL] [Abstract][Full Text] [Related]
40. Characteristics and response to antiretroviral therapy of HIV-1-infected patients born in Africa and living in France.
Breton G; Lewden C; Spire B; Salmon D; Brun-Vézinet F; Duong M; Allavena C; Leport C; Salamon R;
HIV Med; 2007 Apr; 8(3):164-70. PubMed ID: 17461860
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
